ClinicalTrials.gg
CompletedNCT03409068TEACUpdated Apr 23, 2019

C2-C4 Compartment Block Versus Block of Costagliola, in TEAC

An interventional study of C2-C4 compartment anesthetic block and Costagliola block in Somatic Pain and Neuropathic Pain, sponsored by San Salvatore Hospital of L'Aquila. Completed at 1 site in Italy. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-04-23.

Sponsored by San Salvatore Hospital of L'Aquila · Not applicable, Interventional, and Other

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

C2-C4 compartment block compared to the Costaiola block, in the control of persistent postoperative pain (somatic and neuropathic) in patients undergoing carotid thromboendarterectomy

Read the detailed description

A comparative analysis will assess the somatic pain (scores ≥4 on the NRS scale) and neurapathic pain (by the Lindblom roller and Von Frei hair tests) between group A (block group of the C2-C4 compartment ) and the control group B (block group according to Costagliola), during the 3 months after surgery.

02

Conditions studied

  • Somatic Pain
  • Neuropathic Pain

Keywords

  • Carotid thromboendarterectomy
  • Carotidodynia
03

In context

Nociceptive Pain

96 studies on the registry are indexed under Nociceptive Pain; 18 are open to participants now.

This study's enrollment of 100 is above the median of 61 across 62 interventional studies indexed under Nociceptive Pain.

Browse Nociceptive Pain studies →

Lead sponsor

San Salvatore Hospital of L'Aquila is the lead sponsor of 12 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients undergoing to carotid thromboendarterectomy

Exclusion criteria

Exclusion Criteria:

  • ASA status: 4
  • pregnancy
  • > 39,99
  • neurological impairment
  • neck anatomical abnormalities
  • status of sepsis
  • coagulopathy
  • neck cancer
  • neck infections
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    C2-C4 compartment block

    Experimental: the C2-C4 compartment anesthetic block is performed by injecting Levobupivacaine 0.375% 20 mL between the posterior face of the middle scalenous muscle, the anterior face of the posterior scalene muscle and the lower plane of the sternoscleidomastoid muscle.

    Procedure: C2-C4 compartment anesthetic block

  • Active comparator
    Costagliola block

    Active Comparator: the Costagliola anesthetic block is performed by injecting Levobupivacaine 0.375% 20 mL injected in the posterior margin of the sternocleidomastoid muscle and along the anterior border of the same muscle.

    Procedure: Costagliola block

Interventions

  • ProcedureC2-C4 compartment anesthetic block

    C2-C4 compartment anesthetic block is performed by injecting levobupivacaine 0.375% 20 mL between the posterior face of the middle scalenus muscle, the anterior face of the posterior scalene muscle and the lower plane of the sternoscleidomastoid muscle.

    Also known as: Intermediate cervical plexus block

  • ProcedureCostagliola block

    Costagliola block is performed by injected by injecting levobupivacaine 0.375% 20 mL along the anterior and the posterior border of sternocleidomastoid muscle

    Also known as: Superficial cervical plexus block

06

What researchers measure

Primary outcomes

  1. somatic pain

    Somatic pain assessed by Numeric Pain Rating Scale for pain (the 11-point numeric scale ranges from '0' representing "no pain" to '10' representing the "worst pain imaginable"

    Time frame: 3 mounths after surgery

Secondary outcomes

  1. Opiates request

    Request of opiates, assessed in mg of equianalgesic dose of morphine after 3 mouths from surgery

    Time frame: 3 mounths after surgery

  2. Pregabalin request

    Pregabalin request in mg, 3 months after surgery

    Time frame: 3 months

  3. Neuropathic pain

    Presence of neuropathic disturbances, assessed with von Frey hair test and Lindblom test

    Time frame: 3 months

07

Study locations

1 site
  • SS Filippo and Nicola Academic Hospital of Avezzano
    Avezzano, L'Aquila 67051, Italy
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2018 to primary completion in Nov 2018, 8 months.

Of 37 non-industry interventional studies with no phase under Nociceptive Pain, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 32. This study's 8 months is close to that.

Counting every sponsor, half of 42 studies reached it within 8 months; a quarter within 3 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 17, 2018
First posted
Jan 24, 2018
StartActual
Mar 28, 2018
Primary completionActual
Nov 28, 2018
CompletionActual
Jan 18, 2019
Last update
Apr 23, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03409068
Lead sponsor
San Salvatore Hospital of L'Aquila
Responsible party
Emiliano Petrucci (Medical Doctor, San Salvatore Hospital of L'Aquila) — Principal investigator
First posted
Jan 24, 2018
Start date
Mar 28, 2018
Primary completion
Nov 28, 2018
Completion
Jan 18, 2019
Last update
Apr 23, 2019

Study contacts

Emiliano Petrucci, MD
principal investigator · SS Filippo and Nicola Academic Hospital of Avezzano

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion